181 related articles for article (PubMed ID: 36113064)
41. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?
Satkunasingham J; Nik HH; Fischer S; Menezes R; Selzner N; Cattral M; Grant D; Jhaveri K
Liver Transpl; 2018 Apr; 24(4):470-477. PubMed ID: 29080242
[TBL] [Abstract][Full Text] [Related]
42. Magnetic Resonance Imaging-Proton Density Fat Fraction vs. Transient Elastography-Controlled Attenuation Parameter in Diagnosing Non-alcoholic Fatty Liver Disease in Children and Adolescents: A Meta-Analysis of Diagnostic Accuracy.
Jia S; Zhao Y; Liu J; Guo X; Chen M; Zhou S; Zhou J
Front Pediatr; 2021; 9():784221. PubMed ID: 35087774
[No Abstract] [Full Text] [Related]
43. Quantification of Liver Fat by MRI-PDFF Imaging in Patients with Suspected Non-alcoholic Fatty Liver Disease and Its Correlation with Metabolic Syndrome, Liver Function Test and Ultrasonography.
Rodge GA; Goenka MK; Goenka U; Afzalpurkar S; Shah BB
J Clin Exp Hepatol; 2021; 11(5):586-591. PubMed ID: 34511820
[TBL] [Abstract][Full Text] [Related]
44. Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers.
Bannas P; Kramer H; Hernando D; Agni R; Cunningham AM; Mandal R; Motosugi U; Sharma SD; Munoz del Rio A; Fernandez L; Reeder SB
Hepatology; 2015 Nov; 62(5):1444-55. PubMed ID: 26224591
[TBL] [Abstract][Full Text] [Related]
45. Novel Method for Ultrasound-Derived Fat Fraction Using an Integrated Phantom.
Labyed Y; Milkowski A
J Ultrasound Med; 2020 Dec; 39(12):2427-2438. PubMed ID: 32525261
[TBL] [Abstract][Full Text] [Related]
46. Accuracy of common proton density fat fraction thresholds for magnitude- and complex-based chemical shift-encoded MRI for assessing hepatic steatosis in patients with obesity.
Cunha GM; Thai TT; Hamilton G; Covarrubias Y; Schlein A; Middleton MS; Wiens CN; McMillan A; Agni R; Funk LM; Campos GM; Horgan S; Jacobson G; Wolfson T; Gamst A; Schwimmer JB; Reeder SB; Sirlin CB
Abdom Radiol (NY); 2020 Mar; 45(3):661-671. PubMed ID: 31781899
[TBL] [Abstract][Full Text] [Related]
47. Impact of sequential proton density fat fraction for quantification of hepatic steatosis in nonalcoholic fatty liver disease.
Idilman IS; Keskin O; Elhan AH; Idilman R; Karcaaltincaba M
Scand J Gastroenterol; 2014 May; 49(5):617-24. PubMed ID: 24694249
[TBL] [Abstract][Full Text] [Related]
48. Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease.
Tang A; Desai A; Hamilton G; Wolfson T; Gamst A; Lam J; Clark L; Hooker J; Chavez T; Ang BD; Middleton MS; Peterson M; Loomba R; Sirlin CB
Radiology; 2015 Feb; 274(2):416-25. PubMed ID: 25247408
[TBL] [Abstract][Full Text] [Related]
49. Multiparametric ultrasound imaging for early-stage steatosis: Comparison with magnetic resonance imaging-based proton density fat fraction.
Baek J; Basavarajappa L; Margolis R; Arthur L; Li J; Hoyt K; Parker KJ
Med Phys; 2024 Feb; 51(2):1313-1325. PubMed ID: 37503961
[TBL] [Abstract][Full Text] [Related]
50. A comparative study of hepatic steatosis using two different qualitative ultrasound techniques measured based on magnetic resonance imaging-derived proton density fat fraction.
Ogawa S; Kumada T; Gotoh T; Niwa F; Toyoda H; Tanaka J; Shimizu M
Hepatol Res; 2024 Jul; 54(7):638-654. PubMed ID: 38294946
[TBL] [Abstract][Full Text] [Related]
51. Assessment of a high-SNR chemical-shift-encoded MRI with complex reconstruction for proton density fat fraction (PDFF) estimation overall and in the low-fat range.
Park CC; Hooker C; Hooker JC; Bass E; Haufe W; Schlein A; Covarrubias Y; Heba E; Bydder M; Wolfson T; Gamst A; Loomba R; Schwimmer J; Hernando D; Reeder SB; Middleton M; Sirlin CB; Hamilton G
J Magn Reson Imaging; 2019 Jan; 49(1):229-238. PubMed ID: 29707848
[TBL] [Abstract][Full Text] [Related]
52. Ultrasound-derived fat fraction for detection of hepatic steatosis and quantification of liver fat content.
De Robertis R; Spoto F; Autelitano D; Guagenti D; Olivieri A; Zanutto P; Incarbone G; D'Onofrio M
Radiol Med; 2023 Oct; 128(10):1174-1180. PubMed ID: 37568072
[TBL] [Abstract][Full Text] [Related]
53. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
Imajo K; Kessoku T; Honda Y; Tomeno W; Ogawa Y; Mawatari H; Fujita K; Yoneda M; Taguri M; Hyogo H; Sumida Y; Ono M; Eguchi Y; Inoue T; Yamanaka T; Wada K; Saito S; Nakajima A
Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985
[TBL] [Abstract][Full Text] [Related]
54. Reliability of ultrasound hepatorenal index and magnetic resonance imaging proton density fat fraction techniques in the diagnosis of hepatic steatosis, with magnetic resonance spectroscopy as the reference standard.
Tran BV; Ujita K; Taketomi-Takahashi A; Hirasawa H; Suto T; Tsushima Y
PLoS One; 2021; 16(8):e0255768. PubMed ID: 34383812
[TBL] [Abstract][Full Text] [Related]
55. [Quantitative analysis of non-alcoholic fatty liver disease based on MRI proton density fat fraction in the coastal region of Qingdao].
Zhu YL; Xu ZP; Yu WJ; Xin YN; Zhao ZZ; Liu SS; Lyu KR
Zhonghua Gan Zang Bing Za Zhi; 2021 Nov; 29(11):1077-1082. PubMed ID: 34933426
[No Abstract] [Full Text] [Related]
56. Usefulness of US attenuation imaging for the detection and severity grading of hepatic steatosis in routine abdominal ultrasonography.
Kwon EY; Kim YR; Kang DM; Yoon KH; Lee YH
Clin Imaging; 2021 Aug; 76():53-59. PubMed ID: 33549920
[TBL] [Abstract][Full Text] [Related]
57. A meta-analysis on the diagnostic performance of magnetic resonance imaging and transient elastography in nonalcoholic fatty liver disease.
Gu Q; Cen L; Lai J; Zhang Z; Pan J; Zhao F; Yu C; Li Y; Chen C; Chen W; Shen Z
Eur J Clin Invest; 2021 Feb; 51(2):e13446. PubMed ID: 33128454
[TBL] [Abstract][Full Text] [Related]
58. Feasibility of and agreement between MR imaging and spectroscopic estimation of hepatic proton density fat fraction in children with known or suspected nonalcoholic fatty liver disease.
Achmad E; Yokoo T; Hamilton G; Heba ER; Hooker JC; Changchien C; Schroeder M; Wolfson T; Gamst A; Schwimmer JB; Lavine JE; Sirlin CB; Middleton MS
Abdom Imaging; 2015 Oct; 40(8):3084-90. PubMed ID: 26205992
[TBL] [Abstract][Full Text] [Related]
59. Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM Study.
Lemoine M; Assoumou L; De Wit S; Girard PM; Valantin MA; Katlama C; Necsoi C; Campa P; Huefner AD; Schulze Zur Wiesch J; Rougier H; Bastard JP; Stocker H; Mauss S; Serfaty L; Ratziu V; Menu Y; Schlue J; Behrens G; Bedossa P; Capeau J; Ingiliz P; Costagliola D;
J Acquir Immune Defic Syndr; 2019 Apr; 80(4):e86-e94. PubMed ID: 30570529
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of Artificial Intelligence-Calculated Hepatorenal Index for Diagnosing Mild and Moderate Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease.
Zsombor Z; Rónaszéki AD; Csongrády B; Stollmayer R; Budai BK; Folhoffer A; Kalina I; Győri G; Bérczi V; Maurovich-Horvat P; Hagymási K; Kaposi PN
Medicina (Kaunas); 2023 Feb; 59(3):. PubMed ID: 36984470
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
